| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 03/30/2005 | EP1235831B1 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/30/2005 | CN1194977C Tetracyclic fluoroquinolone carboxylic acid, its preparing method and medicinal composition with it as active component |
| 03/29/2005 | US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 03/24/2005 | WO2005026208A2 Chimeric gabab receptor |
| 03/24/2005 | WO2005026177A1 Substituted piperazines of azepines, oxazepines, and thiazepines |
| 03/24/2005 | WO2005025293A2 Fused ring heterocycles as potassium channel modulators |
| 03/24/2005 | WO2004110990A3 Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38 |
| 03/24/2005 | WO2004106293A3 Oxazolyl - and thiazolyl - purine based tricyclic compounds. |
| 03/24/2005 | WO2004064730A3 Compounds, compositions and methods |
| 03/24/2005 | WO2004019283A3 Methods for regulating transcription by targeting quadruplex dna |
| 03/24/2005 | WO2003099217A3 Methods of treating bacterial infections and diseases associated therewith |
| 03/24/2005 | US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 03/24/2005 | US20050065151 Alzheimer's disease; Parkinson's disease; antidepressants |
| 03/24/2005 | US20050065146 Cognition activators; neurodegenerative diseases; anxiolytic agents;psychological disorders; alzheimer's disease; Huntington's disease; antiischemic agents; antiepileptic agenst |
| 03/24/2005 | US20050065118 Compound containing 1,3,4-thiadiazole group; anticancer agents; autoimmune disease; antidiabetic agents |
| 03/24/2005 | US20050065116 Thiazolopyrimidines useful as TNFalpha inhibitors |
| 03/24/2005 | CA2538026A1 Crf antagonists and heterobicyclic compounds |
| 03/24/2005 | CA2536633A1 Fused ring heterocycles as potassium channel modulators |
| 03/24/2005 | CA2536107A1 Substituted piperazines of azepines, oxazepines, and thiazepines |
| 03/24/2005 | CA2535221A1 Chimeric gabab receptor |
| 03/23/2005 | CN1599718A Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 03/22/2005 | US6869956 Such as 4-(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a) quinoxaline; kits; treating arthritis, psoriasis, inflammatory bowel disease, autoimmune diseases and neurodegenerative diseases among others |
| 03/22/2005 | US6869943 Sorbitol dehydrogenase inhibitors |
| 03/17/2005 | WO2004074270B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 03/17/2005 | US20050059823 quinazolinone compounds such as 2-cyclopropyl-4-oxo-3-((p-fluorobenzyl)carbonylamino)-7-fluoro-1,2-dihydroquinazoline; brain and nervous system disorders such as mood disorders or neuropathic pain |
| 03/17/2005 | US20050059687 Modulators of ATP-Binding Cassette transporters |
| 03/17/2005 | US20050059651 Lactam derivatives as antagonists for human 11cby receptors |
| 03/16/2005 | EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 03/16/2005 | CN1596247A Lactam derivatives as antagonists for human 11CBY receptors |
| 03/16/2005 | CN1193014C Novol pyrrole sulphamide compound |
| 03/15/2005 | US6867211 Fused nitrogen biheterocyclic derivatives; immunomodulaters; inhibiting cytokine release |
| 03/15/2005 | US6867198 Agents and methods for the treatment of proliferative diseases |
| 03/10/2005 | WO2005021555A1 Bicyclic piperazine compound and use thereof |
| 03/10/2005 | WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/10/2005 | WO2005020894A2 Rifamycin analogs and uses thereof |
| 03/10/2005 | US20050054678 Nitrogenous five-membered ring compounds |
| 03/10/2005 | US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 03/10/2005 | CA2536378A1 Rifamycin analogs and uses thereof |
| 03/10/2005 | CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/09/2005 | EP1057814B1 Tetrahydrobenzindole derivatives |
| 03/08/2005 | US6864270 Iron binding agents |
| 03/03/2005 | WO2005019228A1 Isothiazoloquinolones and related compounds as anti-infective agents |
| 03/03/2005 | WO2005018638A1 Mitotic kinesin inhibitors |
| 03/03/2005 | WO2005018531A2 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof |
| 03/03/2005 | WO2004082606A8 Fused pyrrole compounds |
| 03/03/2005 | WO2004001058A3 Transcription factor modulating compounds and methods of use thereof |
| 03/03/2005 | US20050049275 Preparing pure (S) form; reacting free base with levorotatory camphor sulfonic acid in dimethylformamide:toluene solvent then precipitating |
| 03/03/2005 | US20050049262 Substituted 2,5-dioxopurines, 2H-1,2,3-triazolyl[4,5-d]pyrimidines, or 1,2,5-thadiazolyl[3,4-d]pyrimidines; antiproliferative, antiinflammatory, and antiarthritic agents; psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, lupus, graft versus host disease |
| 03/03/2005 | CA2533435A1 Mitotic kinesin inhibitors |
| 03/02/2005 | EP1509532A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 03/02/2005 | EP1509501A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/02/2005 | EP1165563B1 Bicyclic heterocycles, method for producing them and their use as herbicides and pharmaceutical agents |
| 03/02/2005 | CN1589153A Preventives/remedies for urinary disturbance |
| 03/01/2005 | US6861440 Antidiabetic agents |
| 03/01/2005 | US6861419 Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/24/2005 | WO2005016937A1 A SYNTHETIC METHOD FOR 6-CHLORO-4-HYDROXY-2-METHYL-2H-THIENO (2,3-e)-1,2-THIAZINE1, 1-DIOXIDE-3-CARBOXYLATE |
| 02/24/2005 | WO2005016934A1 3h-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof |
| 02/24/2005 | WO2005016235A2 Combined use of impdh inhibitors with toll-like receptor agonists |
| 02/24/2005 | US20050043388 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 02/24/2005 | US20050043308 Process for total synthesis of ecteinascidins and intermediates therefor |
| 02/24/2005 | US20050043298 Useful for treating or preventing a variety of antibiotic resistant microbial infections; for example, 3'-hydroxy-5'-(4-ethylcarbamyl-1-piperidinyl)benzoxazinorifamycin |
| 02/24/2005 | CA2535873A1 3h-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof |
| 02/23/2005 | EP1507776A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
| 02/23/2005 | EP1507765A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 02/23/2005 | EP1507756A1 Ccr9 inhibitors and methods of use thereof |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1585768A Pyrazole derivatives as psychopharmaceuticals |
| 02/23/2005 | CN1585744A Process for the preparation of benazepril |
| 02/23/2005 | CN1585639A Antimalarial agents |
| 02/23/2005 | CN1585633A Phenethanolamine derivatives for treatment of respiratory diseases |
| 02/23/2005 | CN1583757A Production of plurizacin |
| 02/23/2005 | CN1190439C Tetracyclic fluoroquinolone carboxylic acid, its preparation method and medicinal composition as active component |
| 02/23/2005 | CN1190437C Pteridine compounds for treatment of psoriasis |
| 02/22/2005 | US6858621 Mbreast and prostate anticancer agents; viricides; alopecia |
| 02/22/2005 | US6858620 For therapy of male erectile dysfunction; female arousal disorder |
| 02/22/2005 | US6858411 Recombinant nucleic acids that encode epothilone polyketide synthase (PKS) are used to express recombinant PKS genes in host cells to produce epothilone derivatives/polyketides; used as cancer drugs, fungicides and immunosuppressants |
| 02/17/2005 | WO2005013979A1 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | WO2005013978A1 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | WO2005013977A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | WO2005013976A1 Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | US20050038242 Pyrrolothiazine and pyrrolothiazephine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 02/17/2005 | US20050038051 Novel molecules for regulating cell death |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 02/17/2005 | CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | CA2534136A1 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | CA2534098A1 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | CA2533976A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | CA2533970A1 Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/16/2005 | CN1582281A Mch受体拮抗剂 Mch receptor antagonist |
| 02/16/2005 | CN1580059A 6-chloro-4-hydroxy-2-methyl-2H-thieno-(2, 3-e)-1, 2-thiazine-1, 1-dioxide-3 |
| 02/10/2005 | US20050032791 Derivatives of sulphonamides, their preparation and use as medicaments |
| 02/10/2005 | US20050032748 Substituted 2,5-dioxopurines, 2H-1,2,3-triazolyl[4,5-d]pyrimidines, or 1,2,5-thadiazolyl[3,4-d]pyrimidines; antiproliferative, antiinflammatory, and antiarthritic agents; psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, lupus, graft versus host disease |
| 02/10/2005 | US20050032650 Fused heterocyclic sulfonylurea compound herbicide containing the same and method of controlling weed with the same |
| 02/10/2005 | CA2533672A1 Novel cyano thiazolides, methods for the production thereof, and use thereof as a medicament |
| 02/09/2005 | EP1385854B1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 02/09/2005 | EP1349839B1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1578625A Substituted thien-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones |